Pharmaceutical Contract Research and Manufacturing Market size is set to grow by USD 121.35 billion from 2022-2027 | The availability of cost-efficient resources in emerging markets to drive the market growth – Technavio
NEW YORK, Nov. 29, 2023 /PRNewswire/ — The Pharmaceutical Contract Research and Manufacturing Market size is estimated to increase by USD 121.35 billion, accelerating at a CAGR of 10.32% from 2022 to 2027, according to Technavio. A major driver behind the growth of the Pharmaceutical Contract
Champagne Market size to grow by USD 2.51 billion from 2023 to 2028, The market share growth by the offline segment will be significant during the forecast period- Technavio
NEW YORK, Nov. 29, 2023 /PRNewswire/ — The champagne market is expected to grow by USD 2.51 billion from 2023 to 2028, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 6% during the forecast period. Growing demand for champagne from millenni
Mexico Alternative Lending Business and Investment Opportunities Report 2023
DUBLIN, Nov. 29, 2023 /PRNewswire/ — The “Mexico Alternative Lending Market Business and Investment Opportunities Databook – 75+ KPIs on Alternative Lending Market Size, By End User, By Finance Model, By Payment Instrument, By Loan Type and Demographics – Q2 2023 Update̶
Leading AI decisioning platform Rich Data Co successfully raises $17.5 million in Series B round to accelerate North America expansion
SYDNEY, Nov. 29, 2023 /PRNewswire/ — Rich Data Co (RDC) – a leading AI decisioning platform that helps banks make high-quality lending decisions efficiently and safely – has successfully raised US$17.5m in its Series B round. The funding round was led by major Australian bank Westpac (ASX
DevOps Platform Market size to grow by USD 25.11 billion from 2022 to 2027, Growth Driven by Reduced Delivery Time- Technavio
NEW YORK, Nov. 29, 2023 /PRNewswire/ — The “DevOps platform market by end-user (IT, BFSI, telecommunication, retail, and others), component (solutions and software), and geography (North America, Europe, APAC, South America, and Middle East and Africa) – Forecast and Analysis 2023
Global Hybrid Aircraft Market Analysis Report 2023-2030: Noise-Free Aircraft and Short-Haul Connectivity, Key to Growth
DUBLIN, Nov. 29, 2023 /PRNewswire/ — The “Hybrid Aircraft Market by Aircraft Type (Regional Transport Aircraft, Business Jets, Light Aircraft, UAVs, AAM), Power Source (Fuel Hybrid, Hydrogen Hybrid), Lift Technology, Mode of Operation, Range, System and Region – Global Forecast to
E-Axle Market size to grow by USD 23.53 billion from 2021 to 2026, Market is fragmented due to the presence of prominent companies like AVL List GmbH, BorgWarner Inc. and BRIST Axle Systems Srl LLC, and many more – Technavio
NEW YORK, Nov. 29, 2023 /PRNewswire/ — The e-axle market is estimated to grow by USD 23.53 billion from 2021 to 2026, growing at a CAGR of 30.74%. The e-axle market is fragmented owing to the presence of many global and regional companies. A few prominent companies that offer e-axle market ar
Veralto Recommends Shareholders Reject Mini-Tender Offer by TRC Capital Investment Corporation
WALTHAM, Mass., Nov. 29, 2023 /PRNewswire/ — Veralto (NYSE: VLTO), a global leader in essential water and product quality solutions dedicated to Safeguarding the World’s Most Vital Resources™, has become aware of an unsolicited “mini-tender offer” made by TRC Capital Invest
Tahoe Conservation Groups File Lawsuit Against Placer County Challenging it to Prepare Required Environmental Impact Report
Proposed Tahoe Basin Area Plan fails to comply with the California Environmental Quality Act (CEQA) AUBURN, Calif., Nov. 29, 2023 /PRNewswire/ — Today, the Friends of West Shore, TahoeCleanAir.org, and North Tahoe Preservation Alliance, (“Conservation Groups”) filed a lawsuit again
Everest Medicines Announces Acceptance of Nefecon® New Drug Applications for the Treatment of Primary IgA Nephropathy in Adult Patients in South Korea
SHANGHAI, Nov. 30, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that its New Drug App
